American Alchemy with Jesse Michels
Can Psychedelics Solve Depression? | Christian Angermayer
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
This week’s American Alchemist is Christian Angermayer: entrepreneur, investor, and head of Apeiron Investment Group, which manages 3.5 Billion Dollars. Born and bred in Germany, Christian is the first investor in Compass Pathways and founder of Atai Life Sciences, demarginalizing psychedelics and bringing them into the mainstream as FDA-approved treatments and therapies for ailments like depression, addiction, and PTSD. Perhaps more interesting than his business track record is his personality; he’s both laser-focused and great at actualizing his goals, visualizing them with a specific method every morning before achieving them. In this interview, we get into everything from his goal setting and visualization methods to psychedelics, to space, to biotech, to crypto, and other sectors that we both invest in.
*** AMERICAN ALCHEMY is an original series hosted by Jesse Michels that explores the frontier of science and tech. Each week, we bring you exclusive interviews with some of the leading thinkers of our time.
INSTAGRAM ➤ https://www.instagram.com/jessemichels
TWITTER ➤ https://twitter.com/AlchemyAmerican
EMAIL/BOOKINGS ➤ usa.alchemy@gmail.com
SUBSCRIBE TO OUR CHANNEL: https://www.youtube.com/channel/UC7eOJzNRWY4l2UTDvIquxYg?app=desktop original music: https://open.spotify.com/artist/6LlLRudDi60Uy4jcmOSEs1
Learn more about your ad choices. Visit megaphone.fm/adchoices